Menu
Recruiting NCT05434026

Chinese Colorectal Cancer Database

— Observational Colonic Cancer Rectal Cancer Prospective Studies

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Colonic Cancer, Rectal Cancer, Prospective Studies. Basic parameters: No limits · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

1. To establish the Chinese people's own clinical data database of colorectal cancer, reflecting the law and characteristics of colorectal cancer patients in China. 2. Based on colorectal cancer surgery, collect clinical data, especially data on clinical manifestations, complications, laboratory tests, auxiliary examinations, postoperative clinical effects, surgical complications, and colorectal cancer recurrence, so as to lead the direction of clinical practice and academic research of colorectal cancer surgery in China. It provides a certain basis for future research on colorectal cancer. 3. Provide academic consultation and data support to national health authorities.

Primary outcome measures

  • Positive rate of circumferential resection margin (CRM) of the specimens [Time frame: 10 days after surgery]
  • The grade score of the specimens integrity [Time frame: 10 days after surgery]
  • The distance between lower tumor margin and the lower reaction margin [Time frame: 10 days after surgery]
  • local recurrence rate [Time frame: 3 years after surgery]
  • the operative time [Time frame: 30 days after surgery]
  • postoperative hospital stay [Time frame: 3 year after surgery]
  • the score of postoperative life [Time frame: 6 months after surgery]
  • disease free survival rate [Time frame: 3-year after surgery]
  • overall survival rate [Time frame: 3-year after surgery]
  • the rate of postoperative complications [Time frame: 30 days after surgery]

Eligibility criteria

Inclusion criteria

  • adenocarcinoma of the colon by biopsy
  • tolerable to surgery
  • be able to understand and willing to participate in this trial with signature

Exclusion criteria

  • can not tolerate the surgery
  • history of serious mental illness
  • the researchers believe the patients should not enrolled in

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

China · 1 center
  • Zhongtao Zhang — Beijing

Identifiers

NCT: NCT05434026 · CCCD

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗